Click here to get full coverage on If You Invested $1,000 in Novartis (NVS) - Stock Titan

If You Invested $1,000 in Novartis (NVS)  Stock Titan

If You Invested $1,000 in Novartis (NVS) - Stock Titan

Click here to get full coverage on Novartis AG (NVS) Announces Final Two-Year Results From Phase III APPLAUSE‑IgAN Study - Yahoo Finance

Novartis AG (NVS) Announces Final Two-Year Results From Phase III APPLAUSE‑IgAN Study  Yahoo Finance

Novartis AG (NVS) Announces Final Two-Year Results From Phase III APPLAUSE‑IgAN Study - Yahoo Finance

Click here to get full coverage on 4 stocks to watch on Friday: LLY, AMZN, NVS, UL (SP500:) - Seeking Alpha

4 stocks to watch on Friday: LLY, AMZN, NVS, UL (SP500:)  Seeking Alpha

4 stocks to watch on Friday: LLY, AMZN, NVS, UL (SP500:) - Seeking Alpha

Click here to get full coverage on Novartis AG (BUE:NVS) Bonds - GuruFocus

Novartis AG (BUE:NVS) Bonds - GuruFocus

Click here to get full coverage on NVIDIA Quadro NVS 160M - Notebookcheck

NVIDIA Quadro NVS 160M - Notebookcheck

Click here to get full coverage on Fund Update: New $108.6M $NVS stock position opened by ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - Quiver Quantitative

Fund Update: New $108.6M $NVS stock position opened by ARROWSTREET CAPITAL, LIMITED PARTNERSHIP  Quiver Quantitative

Fund Update: New $108.6M $NVS stock position opened by ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - Quiver Quantitative

Click here to get full coverage on Novartis (NVS) Stock Falls on $2B Excellergy Acquisition to Expand Allergy Portfolio - TipRanks

Novartis (NVS) Stock Falls on $2B Excellergy Acquisition to Expand Allergy Portfolio  TipRanks

Novartis (NVS) Stock Falls on $2B Excellergy Acquisition to Expand Allergy Portfolio - TipRanks

Click here to get full coverage on Why Analysts Are Closely Watching Novartis AG (NVS) - Yahoo Finance

Why Analysts Are Closely Watching Novartis AG (NVS)  Yahoo Finance

Why Analysts Are Closely Watching Novartis AG (NVS) - Yahoo Finance

Click here to get full coverage on SA analyst upgrades/downgrades: TSLA, SMCI, NVS, KLAC - Seeking Alpha

SA analyst upgrades/downgrades: TSLA, SMCI, NVS, KLAC  Seeking Alpha

SA analyst upgrades/downgrades: TSLA, SMCI, NVS, KLAC - Seeking Alpha

Click here to get full coverage on Novartis (NYSE: NVS) files Form 6-K on multi-tranche USD notes - Stock Titan

Novartis (NYSE: NVS) files Form 6-K on multi-tranche USD notes  Stock Titan

Novartis (NYSE: NVS) files Form 6-K on multi-tranche USD notes - Stock Titan

Click here to get full coverage on FDA Approves NVS' Cosentyx in Hidradenitis Suppurativa for Adolescents - Yahoo Finance

FDA Approves NVS' Cosentyx in Hidradenitis Suppurativa for Adolescents  Yahoo Finance

FDA Approves NVS' Cosentyx in Hidradenitis Suppurativa for Adolescents - Yahoo Finance

Click here to get full coverage on Novartis Promises Growth Despite 'Historic' Patent Cliffs - I Broadly Agree (NYSE:NVS) - Seeking Alpha

Novartis Promises Growth Despite 'Historic' Patent Cliffs - I Broadly Agree (NYSE:NVS)  Seeking Alpha

Novartis Promises Growth Despite 'Historic' Patent Cliffs - I Broadly Agree (NYSE:NVS) - Seeking Alpha

Click here to get full coverage on Jim Cramer is Optimistic About Novartis’ (NVS) Cancer Drug - Yahoo Finance

Jim Cramer is Optimistic About Novartis’ (NVS) Cancer Drug  Yahoo Finance

Jim Cramer is Optimistic About Novartis’ (NVS) Cancer Drug - Yahoo Finance

Click here to get full coverage on Exploring Analyst Estimates for Novartis (NVS) Q4 Earnings, Beyond Revenue and EPS - Yahoo Finance

Exploring Analyst Estimates for Novartis (NVS) Q4 Earnings, Beyond Revenue and EPS  Yahoo Finance

Exploring Analyst Estimates for Novartis (NVS) Q4 Earnings, Beyond Revenue and EPS - Yahoo Finance

Click here to get full coverage on Why Novartis (NVS) is a Top Value Stock for the Long-Term - Yahoo Finance

Why Novartis (NVS) is a Top Value Stock for the Long-Term  Yahoo Finance

Why Novartis (NVS) is a Top Value Stock for the Long-Term - Yahoo Finance

Click here to get full coverage on Novartis (NVS) Announces Plans to Establish a New Radioligand Therapy Manufacturing Site in Denton, Texas - Yahoo Finance

Novartis (NVS) Announces Plans to Establish a New Radioligand Therapy Manufacturing Site in Denton, Texas  Yahoo Finance

Novartis (NVS) Announces Plans to Establish a New Radioligand Therapy Manufacturing Site in Denton, Texas - Yahoo Finance

Click here to get full coverage on Novartis (NVS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Novartis (NVS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates  Yahoo Finance

Novartis (NVS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Click here to get full coverage on Why Novartis (NVS) is a Top Momentum Stock for the Long-Term - Yahoo Finance

Why Novartis (NVS) is a Top Momentum Stock for the Long-Term  Yahoo Finance

Why Novartis (NVS) is a Top Momentum Stock for the Long-Term - Yahoo Finance

Click here to get full coverage on Novartis (NVS) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance

Novartis (NVS) is an Incredible Growth Stock: 3 Reasons Why  Yahoo Finance

Novartis (NVS) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance

Click here to get full coverage on TD Cowen Says Novartis (NVS) Has Strong Growth Path Through 2029 - Yahoo Finance

TD Cowen Says Novartis (NVS) Has Strong Growth Path Through 2029  Yahoo Finance

TD Cowen Says Novartis (NVS) Has Strong Growth Path Through 2029 - Yahoo Finance

Click here to get full coverage on Valve malfunction blamed for failure of Indian satellite to raise its orbit - SpaceNews

Valve malfunction blamed for failure of Indian satellite to raise its orbit  SpaceNews

Valve malfunction blamed for failure of Indian satellite to raise its orbit - SpaceNews

Click here to get full coverage on Novartis: A Mispriced Hedge In A Crowded Equity Market - Seeking Alpha

Novartis: A Mispriced Hedge In A Crowded Equity Market  Seeking Alpha

Novartis: A Mispriced Hedge In A Crowded Equity Market - Seeking Alpha

Click here to get full coverage on Novartis Stock: Value Price, Growth Pipeline (NYSE:NVS) - Seeking Alpha

Novartis Stock: Value Price, Growth Pipeline (NYSE:NVS)  Seeking Alpha

Novartis Stock: Value Price, Growth Pipeline (NYSE:NVS) - Seeking Alpha

Click here to get full coverage on Here's Why Novartis (NVS) is a Strong Value Stock - Yahoo Finance

Here's Why Novartis (NVS) is a Strong Value Stock  Yahoo Finance

Here's Why Novartis (NVS) is a Strong Value Stock - Yahoo Finance

Click here to get full coverage on Compared to Estimates, Novartis (NVS) Q3 Earnings: A Look at Key Metrics - Yahoo Finance

Compared to Estimates, Novartis (NVS) Q3 Earnings: A Look at Key Metrics  Yahoo Finance

Compared to Estimates, Novartis (NVS) Q3 Earnings: A Look at Key Metrics - Yahoo Finance

Click here to get full coverage on AZN, NVO, NVS: What Does Trump’s New 100% Tariff Mean for Pharma Giants? - TipRanks

AZN, NVO, NVS: What Does Trump’s New 100% Tariff Mean for Pharma Giants?  TipRanks

AZN, NVO, NVS: What Does Trump’s New 100% Tariff Mean for Pharma Giants? - TipRanks

Click here to get full coverage on Where is Novartis AG (NVS) Headed? - Finviz

Where is Novartis AG (NVS) Headed?  Finviz

Where is Novartis AG (NVS) Headed? - Finviz

Click here to get full coverage on Novartis AG-Sponsored ADR (NYSE:NVS): A Quality Dividend Stock Backed by Strong Fundamentals - ChartMill

Novartis AG-Sponsored ADR (NYSE:NVS): A Quality Dividend Stock Backed by Strong Fundamentals  ChartMill

Novartis AG-Sponsored ADR (NYSE:NVS): A Quality Dividend Stock Backed by Strong Fundamentals - ChartMill

Click here to get full coverage on NVS Jul 2026 90.000 put (NVS260717P00090000) Stock Price, News, Quote & History - Yahoo! Finance Canada

NVS Jul 2026 90.000 put (NVS260717P00090000) Stock Price, News, Quote & History  Yahoo! Finance Canada

NVS Jul 2026 90.000 put (NVS260717P00090000) Stock Price, News, Quote & History - Yahoo! Finance Canada

Click here to get full coverage on Morgan Stanley Upgrades Novartis (NVS) to Overweight, Raises Price Target to CHF 110 - Yahoo Finance

Morgan Stanley Upgrades Novartis (NVS) to Overweight, Raises Price Target to CHF 110  Yahoo Finance

Morgan Stanley Upgrades Novartis (NVS) to Overweight, Raises Price Target to CHF 110 - Yahoo Finance

Click here to get full coverage on Novartis AG (NVS) Announces US FDA Approval of Itvisma® - Yahoo Finance

Novartis AG (NVS) Announces US FDA Approval of Itvisma®  Yahoo Finance

Novartis AG (NVS) Announces US FDA Approval of Itvisma® - Yahoo Finance

Click here to get full coverage on SA analyst upgrades/downgrades: GM, UBER, UNH, NVS - Seeking Alpha

SA analyst upgrades/downgrades: GM, UBER, UNH, NVS  Seeking Alpha

SA analyst upgrades/downgrades: GM, UBER, UNH, NVS - Seeking Alpha

Click here to get full coverage on NVS Dec 2027 185.000 call (NVS271217C00185000) stock price, news, quote and history - Yahoo Finance UK

NVS Dec 2027 185.000 call (NVS271217C00185000) stock price, news, quote and history  Yahoo Finance UK

NVS Dec 2027 185.000 call (NVS271217C00185000) stock price, news, quote and history - Yahoo Finance UK

Click here to get full coverage on Novartis AG (NYSE:NVS) Q4 2025 earnings call transcript - MSN

Novartis AG (NYSE:NVS) Q4 2025 earnings call transcript  MSN

Novartis AG (NYSE:NVS) Q4 2025 earnings call transcript - MSN

Click here to get full coverage on Novartis: Synnovation Deal And 8% Full-Year 2025 Sales Growth (NYSE:NVS) - Seeking Alpha

Novartis: Synnovation Deal And 8% Full-Year 2025 Sales Growth (NYSE:NVS)  Seeking Alpha

Novartis: Synnovation Deal And 8% Full-Year 2025 Sales Growth (NYSE:NVS) - Seeking Alpha

Click here to get full coverage on NVS Reports Positive Late-Stage Data on Kidney Disease Drug Vanrafia - Zacks Investment Research

NVS Reports Positive Late-Stage Data on Kidney Disease Drug Vanrafia  Zacks Investment Research

NVS Reports Positive Late-Stage Data on Kidney Disease Drug Vanrafia - Zacks Investment Research

Click here to get full coverage on Novartis AG (NVS) Advances $23B U.S. Investment Plan With New RLT Logistics Hub - Yahoo Finance

Novartis AG (NVS) Advances $23B U.S. Investment Plan With New RLT Logistics Hub  Yahoo Finance

Novartis AG (NVS) Advances $23B U.S. Investment Plan With New RLT Logistics Hub - Yahoo Finance

Click here to get full coverage on Novartis AG (NVS) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance

Novartis AG (NVS) Hit a 52 Week High, Can the Run Continue?  Yahoo Finance

Novartis AG (NVS) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance

Click here to get full coverage on Novartis AG (NYSE:NVS) Stands Out as a Dependable Dividend Stock with Strong Fundamentals - ChartMill

Novartis AG (NYSE:NVS) Stands Out as a Dependable Dividend Stock with Strong Fundamentals  ChartMill

Novartis AG (NYSE:NVS) Stands Out as a Dependable Dividend Stock with Strong Fundamentals - ChartMill

Click here to get full coverage on Wilmington Savings Fund Society FSB Sells 26,716 Shares of Novartis AG $NVS - MarketBeat

Wilmington Savings Fund Society FSB Sells 26,716 Shares of Novartis AG $NVS  MarketBeat

Wilmington Savings Fund Society FSB Sells 26,716 Shares of Novartis AG $NVS - MarketBeat

Click here to get full coverage on Novartis AG (NVS): Jim Cramer Wonders Whether Its CEO Is Leaving [UPDATED] - Yahoo Finance

Novartis AG (NVS): Jim Cramer Wonders Whether Its CEO Is Leaving [UPDATED]  Yahoo Finance

Novartis AG (NVS): Jim Cramer Wonders Whether Its CEO Is Leaving [UPDATED] - Yahoo Finance

Click here to get full coverage on Novartis (NVS) Q4 Earnings Beat Estimates Despite Revenue Miss - GuruFocus

Novartis (NVS) Q4 Earnings Beat Estimates Despite Revenue Miss  GuruFocus

Novartis (NVS) Q4 Earnings Beat Estimates Despite Revenue Miss - GuruFocus

Click here to get full coverage on Novartis to build radioligand drug site in Texas (NVS:NYSE) - Seeking Alpha

Novartis to build radioligand drug site in Texas (NVS:NYSE)  Seeking Alpha

Novartis to build radioligand drug site in Texas (NVS:NYSE) - Seeking Alpha

Click here to get full coverage on Novartis AG-Sponsored ADR (NYSE:NVS): A Quality Dividend Stock with Strong Fundamentals - ChartMill

Novartis AG-Sponsored ADR (NYSE:NVS): A Quality Dividend Stock with Strong Fundamentals  ChartMill

Novartis AG-Sponsored ADR (NYSE:NVS): A Quality Dividend Stock with Strong Fundamentals - ChartMill

Click here to get full coverage on Is Novartis (NVS) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Is Novartis (NVS) Stock Outpacing Its Medical Peers This Year?  Yahoo Finance

Is Novartis (NVS) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Click here to get full coverage on Veteran Makes the Most of ‘Rewarding’ NVS Experience - Veterans of Foreign Wars (VFW)

Veteran Makes the Most of ‘Rewarding’ NVS Experience  Veterans of Foreign Wars (VFW)

Veteran Makes the Most of ‘Rewarding’ NVS Experience - Veterans of Foreign Wars (VFW)

Click here to get full coverage on Novartis (NVS) Completes Acquisition of Avidity Biosciences - GuruFocus

Novartis (NVS) Completes Acquisition of Avidity Biosciences  GuruFocus

Novartis (NVS) Completes Acquisition of Avidity Biosciences - GuruFocus

Click here to get full coverage on Novartis: Assessing The Impact Of Entresto Generics (NYSE:NVS) - Seeking Alpha

Novartis: Assessing The Impact Of Entresto Generics (NYSE:NVS)  Seeking Alpha

Novartis: Assessing The Impact Of Entresto Generics (NYSE:NVS) - Seeking Alpha

Click here to get full coverage on ISRO blames wiring fault for NVS-02 loss - MSN

ISRO blames wiring fault for NVS-02 loss  MSN

ISRO blames wiring fault for NVS-02 loss - MSN

Click here to get full coverage on Novartis AG-Sponsored ADR (NYSE:NVS) Presents a Compelling Value Investment Case - ChartMill

Novartis AG-Sponsored ADR (NYSE:NVS) Presents a Compelling Value Investment Case  ChartMill

Novartis AG-Sponsored ADR (NYSE:NVS) Presents a Compelling Value Investment Case - ChartMill

Click here to get full coverage on Novartis AG (NVS) Strengthens Cardiovascular Unit with Tourmaline Bio Acquisition - Yahoo Finance

Novartis AG (NVS) Strengthens Cardiovascular Unit with Tourmaline Bio Acquisition  Yahoo Finance

Novartis AG (NVS) Strengthens Cardiovascular Unit with Tourmaline Bio Acquisition - Yahoo Finance

Click here to get full coverage on Novartis (NVS) Downgraded to Sell by Goldman Sachs | NVS Stock N - GuruFocus

Novartis (NVS) Downgraded to Sell by Goldman Sachs | NVS Stock N  GuruFocus

Novartis (NVS) Downgraded to Sell by Goldman Sachs | NVS Stock N - GuruFocus

Click here to get full coverage on NVS Reports Positive Late-Stage Data on Kidney Disease Drug - Zacks Investment Research

NVS Reports Positive Late-Stage Data on Kidney Disease Drug  Zacks Investment Research

NVS Reports Positive Late-Stage Data on Kidney Disease Drug - Zacks Investment Research

Click here to get full coverage on Novartis (NVS) Enters $1.7 Billion Development Deal, Says Report - Finviz

Novartis (NVS) Enters $1.7 Billion Development Deal, Says Report  Finviz

Novartis (NVS) Enters $1.7 Billion Development Deal, Says Report - Finviz

Click here to get full coverage on Novartis (NVS) Reports Robust Q4 Sales Growth and Pipeline Advan - GuruFocus

Novartis (NVS) Reports Robust Q4 Sales Growth and Pipeline Advan  GuruFocus

Novartis (NVS) Reports Robust Q4 Sales Growth and Pipeline Advan - GuruFocus

Click here to get full coverage on Novartis AG (NVS) Gets Upgraded to Overweight from Neutral by JPMorgan - Finviz

Novartis AG (NVS) Gets Upgraded to Overweight from Neutral by JPMorgan  Finviz

Novartis AG (NVS) Gets Upgraded to Overweight from Neutral by JPMorgan - Finviz

Click here to get full coverage on Novartis' Moonshot Cancer Therapy Could Be Future Growth Driver - MarketBeat

Novartis' Moonshot Cancer Therapy Could Be Future Growth Driver  MarketBeat

Novartis' Moonshot Cancer Therapy Could Be Future Growth Driver - MarketBeat

Click here to get full coverage on NVS Ups Sales Projections as Key Drugs and Collaborations Fuel Growth - Zacks Investment Research

NVS Ups Sales Projections as Key Drugs and Collaborations Fuel Growth  Zacks Investment Research

NVS Ups Sales Projections as Key Drugs and Collaborations Fuel Growth - Zacks Investment Research

Click here to get full coverage on Novartis AG-Sponsored ADR (NYSE:NVS): A Quality Dividend Stock with Strong Financials - ChartMill

Novartis AG-Sponsored ADR (NYSE:NVS): A Quality Dividend Stock with Strong Financials  ChartMill

Novartis AG-Sponsored ADR (NYSE:NVS): A Quality Dividend Stock with Strong Financials - ChartMill

Click here to get full coverage on NVS Ups Sales Projections as Key Drugs and Collaborations Fuel Growth - Finviz

NVS Ups Sales Projections as Key Drugs and Collaborations Fuel Growth  Finviz

NVS Ups Sales Projections as Key Drugs and Collaborations Fuel Growth - Finviz

Click here to get full coverage on Novartis AG (NVS) Shares Down 3.08% on Mar 5 - GuruFocus

Novartis AG (NVS) Shares Down 3.08% on Mar 5  GuruFocus

Novartis AG (NVS) Shares Down 3.08% on Mar 5 - GuruFocus

Click here to get full coverage on Burger King Donations Fund VFW Service Officers - Veterans of Foreign Wars (VFW)

Burger King Donations Fund VFW Service Officers  Veterans of Foreign Wars (VFW)

Burger King Donations Fund VFW Service Officers - Veterans of Foreign Wars (VFW)

Click here to get full coverage on Novartis (NVS) Announces 2026 Dividend Proposal - GuruFocus

Novartis (NVS) Announces 2026 Dividend Proposal  GuruFocus

Novartis (NVS) Announces 2026 Dividend Proposal - GuruFocus

Click here to get full coverage on NVS to Acquire TRML, Add Phase III Cardiovascular Drug to Pipeline - Yahoo Finance

NVS to Acquire TRML, Add Phase III Cardiovascular Drug to Pipeline  Yahoo Finance

NVS to Acquire TRML, Add Phase III Cardiovascular Drug to Pipeline - Yahoo Finance

Click here to get full coverage on Why Novartis Is Still A 'Buy' After 15% Surge - Seeking Alpha

Why Novartis Is Still A 'Buy' After 15% Surge  Seeking Alpha

Why Novartis Is Still A 'Buy' After 15% Surge - Seeking Alpha

Click here to get full coverage on Novartis (NVS) Secures License for Peptide-Based Radioligand The - GuruFocus

Novartis (NVS) Secures License for Peptide-Based Radioligand The  GuruFocus

Novartis (NVS) Secures License for Peptide-Based Radioligand The - GuruFocus

Click here to get full coverage on Novartis (NVS) Upgraded to Buy with Promising Outlook - GuruFocus

Novartis (NVS) Upgraded to Buy with Promising Outlook  GuruFocus

Novartis (NVS) Upgraded to Buy with Promising Outlook - GuruFocus

Click here to get full coverage on VFW Reaches $16.2 Billion Cumulative Milestone for Represented Veterans - Veterans of Foreign Wars (VFW)

VFW Reaches $16.2 Billion Cumulative Milestone for Represented Veterans  Veterans of Foreign Wars (VFW)

NVS

Price Chart

Key Statistics

Technicals

About NVS

Latest News

If You Invested $1,000 in Novartis (NVS) - Stock Titan

Novartis AG (NVS) Announces Final Two-Year Results From Phase III APPLAUSE‑IgAN Study - Yahoo Finance

4 stocks to watch on Friday: LLY, AMZN, NVS, UL (SP500:) - Seeking Alpha

Advanced Charts

Top Gainers

Top Losers